Nektar Therapeutics Other Non-Current Assets
Nektar Therapeutics (NKTR) had Other Non-Current Assets of $16.67 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Noncurrent $16.67M.
- 2026-03-31: Other Assets, Noncurrent $11.24M.
- 2025-12-31: Other Assets, Noncurrent $14.14M; Other Assets, Noncurrent as first filed $5.65M.
- 2025-09-30: Other Assets, Noncurrent $5.16M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $16.67M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.24M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $14.14M 10-Q · filed 2026-08-14 | $5.65M 10-K · filed 2026-03-13 |
| 2025-09-30 | $5.16M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $5.02M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $5.39M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $4.65M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $4.52M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $4.31M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $4.66M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $4.64M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $4.52M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.65M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.41M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.25M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $2.32M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $2.23M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $1.52M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $2.74M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $1.84M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $344.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.44M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $1.46M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.42M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.41M 10-Q · filed 2020-08-07 | |
| 2019-12-31 | $344.00K 10-K · filed 2021-02-26 | $1.01M 10-K · filed 2020-02-28 |
| 2019-09-30 | $2.38M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.40M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.37M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.24M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $3.39M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.36M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $789.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $994.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $767.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.10M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $865.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $817.00K 10-K · filed 2018-03-01 | $517.00K 10-K · filed 2017-03-01 |
| 2016-09-30 | $519.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $504.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $681.00K 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $754.00K 10-K · filed 2017-03-01 | $4.17M 10-K · filed 2016-02-29 |
| 2015-09-30 | $13.86M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $5.76M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $6.15M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $6.55M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $7.01M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $7.34M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $7.77M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $8.17M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $8.51M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $9.04M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $9.25M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $9.44M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $9.73M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $5.69M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $5.34M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $999.00K 10-K · filed 2013-03-01 | |
| 2011-09-30 | $845.00K 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $936.00K 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $976.00K 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $972.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |